INTRODUCTION
Gastric cancer is one of the most common malignancies worldwide. Although improvements in diagnostic instruments and therapeutic techniques have increased survival in patients with gastric cancer, it is still the second leading cause of cancer-related deaths. 1, 2 The prognosis of gastric cancer is related to the development of recurrence and metastasis. Gastric cancer frequently disseminates through the hematogenous, lymphatic, or direct peritoneal route. In particular, peritoneal dissemination is the most common mode of metastasis in advanced gastric cancer. 3, 4 Clinically, peritoneal wash cytology has a low sensitivity rate, and the prediction of recurrence is difficult. 5, 6 Recurrent gastric cancers could be complicated by and combined with hematogenous, lymphatic and peritoneal metastases. A highly sensitive and specified marker is necessary for the improvement of therapeutic efficacy. Moreover, to prevent the recurrence of gastric cancer following curative resection, early selection of high-risk patients and aggressive adjuvant therapy are very important. It has previously been reported that recurrence and metastasis were frequent in the upper third tumor location, carcinomas involving the serosa, and neoplasms with an advanced nodal state. 4, [7] [8] [9] [10] [11] However, it was difficult to assess the overall impact of recurrence. analysis of CEA and CK20 in the peritoneal lavage fluid was useful in predicting the recurrence, identifying significant independent prognostic factors of nodal metastasis in patients undergoing a curative resection for gastric cancer. 18 Contrary to the above result, another report asserted that the sensitivity and specificity of RT-PCR analysis of CEA and CK20 were insufficient, and their clinical impact would be small. 19 We aim to evaluate whether the molecular diagnosis with RT-PCR assay for CEA and CK20 messenger RNA (mRNA) using preoperative peritoneal washing fluid is useful to predict the recurrence in patients with advanced gastric cancer following curative resection.
SUBJECTS AND METHODS

Patients
This study was conducted at St. Vincent Hospital, the Catholic University of Korea. We prospectively enrolled 132 patients with gastric cancers who had previously received operations between January 2010 and January 2013. Patients eligible for this study were identified preoperatively as having histological gastric adenocarcinoma. They were offered participation, and were required to provide informed consent.
After curative operation, adjuvant combination chemotherapy was administered in patients with stage II and III of the disease classified by the 7th edition of the American Joint Committee on Cancer cancer staging. 20 We treated pa- 12 months for the next years). Recurrent and mortality events were recorded and disease free survival (DFS) was calculated to assess the prognosis.
Methods
Before manipulation of the primary tumor, normal saline was introduced into the right upper abdomen, left upper abdomen, and pelvis, and then aspirated after gentle agitation.
Samples were collected. One of the samples was sent to the pathology department for cytologic examination with conventional Papanicolaou staining. Additionally, 50 mL of the samples was collected into a specimen cup and transported on ice to the laboratory for RNA isolation.
Negative peritoneal washing was obtained from a patient undergoing laparoscopy for benign condition (tuberculous peritonitis). Positive control was a patient with carcinoma-
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The Korean Journal of Gastroenterology Both CEA and CK20 mRNA levels were normalized to the GAPDH mRNA level, and the ratios of CEA/GAPDH and CK20/GAPDH were calculated (the CEA or CK20 mRNA level divided by GAPDH mRNA×10 7 ) ( Fig. 1 ).
Statistical analysis
For quantitative variables, the mean and its standard devia- 
Ethics statement
This study was approved by the Institutional Review Board of the Catholic University of Korea (VC09TISI0005).
RESULTS
We excluded patients with stage IA (n=28) early gastric cancer, positive cytologic examination of peritoneal washings (n=7), and those who were lost to follow up (n=18 Table 2 ).
All cases of recurrence were CEA positive, and 6 cases were CK20 positive. The positive and negative predictive values of CEA were 32.0% and 100%, respectively, whereas those of CK20 were 37.5% and 71.4%, respectively. DFS of CK20-negative cases was 36.17±20.28 months and that of CK20-positive cases was 32.06±22.95 months (p=0.39).
There was no statistically significant difference between the two groups (Fig. 2) .
DISCUSSION
In advanced gastric cancer patients, about 80% of recurrent events occurred within the first two years postoperation. 4, 21 224 김연지 등. 위암 환자의 미세전이
The Korean Journal of Gastroenterology Direct peritoneal recurrence was the most prevalent pattern, followed by hematogenous metastasis. In general, it has been established that tumors with smaller sizes has greater chemotherapeutic effect. With improved methods for detecting and diagnosing micrometastasis, it is likely for the prognosis of advanced gastric cancer to improve by appropriate adjuvant therapy. Thus, high risk patients with high risk of gastric cancer recurrence will be able to undergo more aggressive therapeutic strategies.
In one Japanese study, relatively high sensitivity and specificity rates of RT-PCR assay for CEA mRNA in peritoneal washing fluid were demonstrated, and the survival of CEA mRNA-positive patients was as poor as that of cytology-positive patients. 14 Other tumor markers have been studied in peritoneal washings of gastric cancer patients. With respect to the RT-PCR assay for CK 20 mRNA alone, sufficient sensitivity was not shown to replace CEA. 19 The RT-PCR assay for matrix metalloproteinase-7 (MMP-7) mRNA was able to detect micrometastatic cancer cells due to the lack of signal of MMP-7 mRNA from normal gastric mucosa, mesothelial cells, fibroblasts, peripheral blood, and lavage fluid. However, the sensitivity for the prediction of peritoneal dissemination by RT-PCR assay for MMP-7 mRNA was only 33%, and that for the combination analysis using cytology and RT-PCR assay for MMP-7 mRNA was 62%. 13 These previous studies had a limitation because they were performed using RT-PCR assay for CEA mRNA combined with cytology results, and the sole efficacy of RT-PCR assay might have been overestimated.
Contrastingly, our study was performed with the use of RT-PCR assay only in patients with curative R0 resection.
In the studies of CEA and CK20 mRNA in peritoneal washing fluid, false-positive results were reported. When the RT-PCR technique was utilized, the diagnostic specificity was problematic. The main source of such false-positive results is thought to be the amplification of low-level CEA from the peritoneal inflammatory cells. 22 In the case of CK20, falsepositive results were attributed to the aberrant expression of mRNA originated from granulocytes. 23 In the present study, RT-PCR assay for CEA mRNA showed a high rate of false-positive results, and the discriminatory power for the prediction of recurrence was low. Disappointingly, the specificity provided by RT-PCR assay for CEA mRNA was only 7.3%, and the sensitivity for CK20 mRNA was no more than 25% in this study. In patients with negative yields on both assays, there was no recurrence during the follow-up period. The negative results may convince surgeons to perform a curative R0 resection.
Locally advanced gastric cancer, defined as T4 in which the tumor perforates serosa (T4a) or invades adjacent structures (T4b), often has a poor prognosis. In previous reports, the overall survival rate for locally advanced gastric cancer patients was under 20% and approximately 30% for those who can undergo surgical resection. 24, 25 In our study, only gastric cancer in the T4 stage at the initial diagnosis was an independent risk factor for recurrence, and 30.4% of the patients had recurrent disease. A more potent and aggressive adjuvant therapy is needed after curative resection of locally advanced gastric cancer (T4 gastric cancer).
There are potential limitations to this study. First, this study has a relatively small sample size and may include selection bias. To overcome these issues, we designed a prospective study and pursued a relatively long-term follow-up testing.
Second, methodologically, we choose the markers of peritoneal micrometastasis to predict recurrence. Although peritoneal micrometastasis was an important factor for the recurrent disease, there were various routes of recurrence through the blood vessel, lymphatics, and direct peritoneum.
Clinically, recurrent diseases are complex and simultaneous multiple metastatic lesions are often found. In this study, there were multiple lesions in more than 40% of the cases.
Because the most common pattern of recurrence after curative resection was peritoneal carcinomatosis, 26 the presence of direct peritoneal metastasis was an important factor for the prognosis.
In conclusion, it is unlikely that the RT-PCR results of tumor markers, CEA and CK20, in peritoneal washings can predict recurrence. Negative results can convince surgeons to perform a curative R0 resection. For the prediction of recurrence, better markers with higher sensitivity and specificity are necessary.
